Astaxanthin for Alzheimer's Disease
Also known as: AstaREAL, Haematococcus pluvialis extract
Astaxanthin crosses the BBB and reduces neuroinflammation and oxidative stress — two key drivers of Alzheimer's progression.
Mechanism of Action
Astaxanthin inhibits BACE1 and reduces amyloid-beta production, suppresses neuroinflammatory cytokines through NF-κB/MAPK inhibition, and protects hippocampal neurons from oxidative damage. Its membrane-spanning antioxidant activity is unique among carotenoids.
General mechanism: Carotenoid antioxidant spanning lipid bilayers. Nrf2 activator, NF-κB/STAT3 inhibitor, mitochondrial membrane protector.
Current Evidence
Preclinical models show improved cognitive function and reduced amyloid pathology. Human studies show cognitive benefit in healthy elderly with astaxanthin supplementation.
Clinical Status: Phase I/II for cognitive health. AD-specific trials planned.
Safety Profile
Very safe. Naturally occurring. FDA GRAS status. No significant side effects. May cause orange skin tint at very high doses.
Key Research Questions
- Can astaxanthin reduce BACE1 activity in AD patients?
- Does long-term astaxanthin supplementation reduce AD conversion risk?